These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3691620)

  • 1. Propranolol pharmacokinetics and pharmacodynamics after single doses and at steady-state.
    Lalonde RL; Pieper JA; Straka RJ; Bottorff MB; Mirvis DM
    Eur J Clin Pharmacol; 1987; 33(3):315-8. PubMed ID: 3691620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonlinear pharmacokinetics of unbound propranolol after oral administration.
    Straka RJ; Lalonde RL; Pieper JA; Bottorff MB; Mirvis DM
    J Pharm Sci; 1987 Jul; 76(7):521-4. PubMed ID: 3668812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic study of a new sustained release preparation of propranolol in normal healthy volunteers.
    Biswas NR; Garg SK; Lal R; Kumar N; Gyawali K; Narendranath KA; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1988 Sep; 26(9):436-8. PubMed ID: 3198297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacodynamics and pharmacokinetics of conventional and long-acting propranolol.
    Garg DC; Jallad NS; Mishriki A; Chalavarya G; Kraml M; Fencik M; Weidler DJ
    J Clin Pharmacol; 1987; 27(5):390-6. PubMed ID: 3693583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of long-acting propranolol 60-mg capsules: a comparative evaluation.
    Marino MR; Dey M; Garg DC; Jallad NS; Dorick DM; Martinez JJ; Weidler DJ
    J Clin Pharmacol; 1987 Nov; 27(11):885-91. PubMed ID: 3429696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of propranolol after single and multiple dosing with sustained release propranolol or propranolol CR (innopran XL) , a new chronotherapeutic formulation.
    Sica D; Frishman WH; Manowitz N
    Heart Dis; 2003; 5(3):176-81. PubMed ID: 12783630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic studies with a new controlled-release formulation of propranolol in normal volunteers: a comparison with other commercially available formulations.
    Perucca E; Grimaldi R; Gatti G; Caravaggi M; Crema F; Lecchini S; Frigo GM
    Br J Clin Pharmacol; 1984 Jul; 18(1):37-43. PubMed ID: 6743489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative pharmacokinetic study of conventional propranolol and long acting preparation of propranolol in patients with cirrhosis and normal controls.
    Watson RG; Bastain W; Larkin KA; Hayes JR; McAinsh JA; Shanks RG
    Br J Clin Pharmacol; 1987 Oct; 24(4):527-35. PubMed ID: 3689632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of propranolol pharmacokinetics and pharmacodynamics by quinidine in man.
    Yasuhara M; Yatsuzuka A; Yamada K; Okumura K; Hori R; Sakurai T; Kawai C
    J Pharmacobiodyn; 1990 Nov; 13(11):681-7. PubMed ID: 2093126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in plasma propranolol caused by nicardipine is dependent on the delivery rate of propranolol.
    Vercruysse I; Massart DL; Dupont AG
    Eur J Clin Pharmacol; 1995; 49(1-2):121-5. PubMed ID: 8751033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic comparison of two doses of long acting propranolol (80 and 160 mg) in healthy subjects.
    Flouvat B; Berlin I; Cournot A; Robinet D; Duchier J; Sarmini H; Rossi A
    Br J Clin Pharmacol; 1989 May; 27(5):539-45. PubMed ID: 2757878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of l-propranolol during repetitive dosing in normal and uranyl nitrate-induced renal failure rats.
    Terao N; Shen DD
    J Pharmacokinet Biopharm; 1984 Oct; 12(5):479-93. PubMed ID: 6520744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racemic (R,S)-propranolol versus half-dosed optically pure (S)-propranolol in humans at steady state: Hemodynamic effects, plasma concentrations, and influence on thyroid hormone levels.
    Stoschitzky K; Lindner W; Egginger G; Brunner F; Obermayer-Pietsch B; Passath A; Klein W
    Clin Pharmacol Ther; 1992 Apr; 51(4):445-53. PubMed ID: 1563214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propranolol: pooled Michaelis-Menten parameters and the effect of input rate on bioavailability.
    Wagner JG
    Clin Pharmacol Ther; 1985 May; 37(5):481-7. PubMed ID: 3987171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steady state relative bioavailability and pharmacokinetics of oral propranolol in black and white North Americans.
    Sharoky M; Perkal M; Turner R; Lesko LJ
    Biopharm Drug Dispos; 1988; 9(5):447-56. PubMed ID: 3224162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pharmacokinetic interaction study of avitriptan and propranolol.
    Marathe PH; Greene DS; Kollia GD; Barbhaiya RH
    Clin Pharmacol Ther; 1998 Mar; 63(3):367-78. PubMed ID: 9542480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propranolol pharmacodynamic modeling using unbound and total concentrations in healthy volunteers.
    Lalonde RL; Straka RJ; Pieper JA; Bottorff MB; Mirvis DM
    J Pharmacokinet Biopharm; 1987 Dec; 15(6):569-82. PubMed ID: 3450842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steady-state pharmacokinetics of propranolol enantiomers in healthy male volunteers.
    Paradiso-Hardy FL; Walker SE; Bowles SK
    Int J Clin Pharmacol Ther; 1998 Jul; 36(7):370-5. PubMed ID: 9707351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct enantioselective determination of (R)- and (S)-propranolol in human plasma. Application to pharmacokinetic studies.
    Egginger G; Lindner W; Brunner G; Stoschitzky K
    J Pharm Biomed Anal; 1994 Dec; 12(12):1537-45. PubMed ID: 7696378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo studies on slow release propranolol hydrochloride suppositories. Pharmacokinetic and pharmacodynamic evaluation.
    Sastri MS; Satyanarayana NV; Krishna DR; Diwan PV
    Arzneimittelforschung; 1993 Mar; 43(3):320-3. PubMed ID: 8489559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.